At $2 Million, New Drug For Rare Genetic Disease Set To Be Most Expensive Ever05:33
Download

Play

The Food and Drug Administration is expected to approve a drug with an extremely high price tag. The new drug, called Zolgensma, treats a genetic disease called spinal muscular atrophy and is expected to cost about $2 million. WBUR's Carey Goldberg (@goldbergcarey) reports.

This segment aired on May 15, 2019.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news